Coronary Artery Disease
Conditions
Keywords
Heart team, Decision making, Complex coronary artery disease
Brief summary
The purposes of this study are 1) to explore the variability of decisions between different heart teams in complex coronary artery disease; 2) to evaluate the reasons of the discrepancy in decision making.
Detailed description
Heart team has been recommended by guideline for optimizing the decision making for patients with complex coronary artery diseases (CAD). However, prior studies have demonstrated that heart team decision might have poor reproducibility, and the variability of heart team decision remains unknown. Thus, the investigators designed a single-center, retrospective, cross-sectional study to explore the decision variability of heart team in CAD patients. The investigators will retrospectively recruit patients with angiographically confirmed 3-vessel or left main disease from a coronary angiography database at Fuwai hospital. Patients' baseline information will be collected. And different heart teams will be established and made decisions for the enrolled patients. First, the investigators will assess the decision variability between different heart teams. Secondary, the investigators will evaluate the reason of discrepancy by qualitative and quantitative analysis.
Interventions
OTHERNo intervention
No intervention
Sponsors
China National Center for Cardiovascular Diseases
Study design
Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients with angiographically confirmed 3-vessel disease or left main disease
Exclusion criteria
* Prior percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) * Myocardial infarction with acute phase judged by Electrocardiograph or biomarkers * Combined with severe valvular disease, great vessel disease or huge ventricular aneurysm which need surgery * Combined with atrial fibrillation or severe arrhythmia
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Kappa value of decisions | at the end of enrollment (6 months) | Kappa value of decisions between different heart teams |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Concordance rate of decisions | at the end of enrollment (6 months) | Concordance rate of decisions between different heart teams |
Countries
China
Outcome results
None listed